Global Antiretroviral Therapy Market Size, Status and Forecast 2018-2025

Published: Sep, 2018 | Pages: 95 | Publisher: QYResearch
Industry: Healthcare | Report Format: Electronic (PDF)

This report focuses on the global Antiretroviral Therapy status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Antiretroviral Therapy development in United States, Europe and China.

In 2017, the global Antiretroviral Therapy market size was million US$ and it is expected to reach million US$ by the end of 2025, with a CAGR of during 2018-2025.

The key players covered in this study
Gilead
F. Hoffmann-La Roche
ViiV Healthcare
Boehringer Ingelheim
Janssen Pharmaceuticals
Mylan
Abbvie
Bionor Pharma
Vertex Pharmaceuticals

Market segment by Type, the product can be split into
NNRTIs
NRTI
Multiclass Combination Products
Integrase Inhibitors

Market segment by Application, split into
Hospital
Clinic
Other

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Antiretroviral Therapy status, future forecast, growth opportunity, key market and key players.
To present the Antiretroviral Therapy development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Antiretroviral Therapy are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025
For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

 Table of Contents

1 Report Overview
    1.1 Study Scope
    1.2 Key Market Segments
    1.3 Players Covered
    1.4 Market Analysis by Type
        1.4.1 Global Antiretroviral Therapy Market Size Growth Rate by Type (2013-2025)
        1.4.2 NNRTIs
        1.4.3 NRTI
        1.4.4 Multiclass Combination Products
        1.4.5 Integrase Inhibitors
    1.5 Market by Application
        1.5.1 Global Antiretroviral Therapy Market Share by Application (2013-2025)
        1.5.2 Hospital
        1.5.3 Clinic
        1.5.4 Other
    1.6 Study Objectives
    1.7 Years Considered

2 Global Growth Trends
    2.1 Antiretroviral Therapy Market Size
    2.2 Antiretroviral Therapy Growth Trends by Regions
        2.2.1 Antiretroviral Therapy Market Size by Regions (2013-2025)
        2.2.2 Antiretroviral Therapy Market Share by Regions (2013-2018)
    2.3 Industry Trends
        2.3.1 Market Top Trends
        2.3.2 Market Drivers
        2.3.3 Market Opportunities

3 Market Share by Key Players
    3.1 Antiretroviral Therapy Market Size by Manufacturers
        3.1.1 Global Antiretroviral Therapy Revenue by Manufacturers (2013-2018)
        3.1.2 Global Antiretroviral Therapy Revenue Market Share by Manufacturers (2013-2018)
        3.1.3 Global Antiretroviral Therapy Market Concentration Ratio (CR5 and HHI)
    3.2 Antiretroviral Therapy Key Players Head office and Area Served
    3.3 Key Players Antiretroviral Therapy Product/Solution/Service
    3.4 Date of Enter into Antiretroviral Therapy Market
    3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
    4.1 Global Antiretroviral Therapy Market Size by Type (2013-2018)
    4.2 Global Antiretroviral Therapy Market Size by Application (2013-2018)

5 United States
    5.1 United States Antiretroviral Therapy Market Size (2013-2018)
    5.2 Antiretroviral Therapy Key Players in United States
    5.3 United States Antiretroviral Therapy Market Size by Type
    5.4 United States Antiretroviral Therapy Market Size by Application

6 Europe
    6.1 Europe Antiretroviral Therapy Market Size (2013-2018)
    6.2 Antiretroviral Therapy Key Players in Europe
    6.3 Europe Antiretroviral Therapy Market Size by Type
    6.4 Europe Antiretroviral Therapy Market Size by Application

7 China
    7.1 China Antiretroviral Therapy Market Size (2013-2018)
    7.2 Antiretroviral Therapy Key Players in China
    7.3 China Antiretroviral Therapy Market Size by Type
    7.4 China Antiretroviral Therapy Market Size by Application

8 Japan
    8.1 Japan Antiretroviral Therapy Market Size (2013-2018)
    8.2 Antiretroviral Therapy Key Players in Japan
    8.3 Japan Antiretroviral Therapy Market Size by Type
    8.4 Japan Antiretroviral Therapy Market Size by Application

9 Southeast Asia
    9.1 Southeast Asia Antiretroviral Therapy Market Size (2013-2018)
    9.2 Antiretroviral Therapy Key Players in Southeast Asia
    9.3 Southeast Asia Antiretroviral Therapy Market Size by Type
    9.4 Southeast Asia Antiretroviral Therapy Market Size by Application

10 India
    10.1 India Antiretroviral Therapy Market Size (2013-2018)
    10.2 Antiretroviral Therapy Key Players in India
    10.3 India Antiretroviral Therapy Market Size by Type
    10.4 India Antiretroviral Therapy Market Size by Application

11 Central & South America
    11.1 Central & South America Antiretroviral Therapy Market Size (2013-2018)
    11.2 Antiretroviral Therapy Key Players in Central & South America
    11.3 Central & South America Antiretroviral Therapy Market Size by Type
    11.4 Central & South America Antiretroviral Therapy Market Size by Application

12 International Players Profiles
    12.1 Gilead
        12.1.1 Gilead Company Details
        12.1.2 Company Description and Business Overview
        12.1.3 Antiretroviral Therapy Introduction
        12.1.4 Gilead Revenue in Antiretroviral Therapy Business (2013-2018)
        12.1.5 Gilead Recent Development
    12.2 F. Hoffmann-La Roche
        12.2.1 F. Hoffmann-La Roche Company Details
        12.2.2 Company Description and Business Overview
        12.2.3 Antiretroviral Therapy Introduction
        12.2.4 F. Hoffmann-La Roche Revenue in Antiretroviral Therapy Business (2013-2018)
        12.2.5 F. Hoffmann-La Roche Recent Development
    12.3 ViiV Healthcare
        12.3.1 ViiV Healthcare Company Details
        12.3.2 Company Description and Business Overview
        12.3.3 Antiretroviral Therapy Introduction
        12.3.4 ViiV Healthcare Revenue in Antiretroviral Therapy Business (2013-2018)
        12.3.5 ViiV Healthcare Recent Development
    12.4 Boehringer Ingelheim
        12.4.1 Boehringer Ingelheim Company Details
        12.4.2 Company Description and Business Overview
        12.4.3 Antiretroviral Therapy Introduction
        12.4.4 Boehringer Ingelheim Revenue in Antiretroviral Therapy Business (2013-2018)
        12.4.5 Boehringer Ingelheim Recent Development
    12.5 Janssen Pharmaceuticals
        12.5.1 Janssen Pharmaceuticals Company Details
        12.5.2 Company Description and Business Overview
        12.5.3 Antiretroviral Therapy Introduction
        12.5.4 Janssen Pharmaceuticals Revenue in Antiretroviral Therapy Business (2013-2018)
        12.5.5 Janssen Pharmaceuticals Recent Development
    12.6 Mylan
        12.6.1 Mylan Company Details
        12.6.2 Company Description and Business Overview
        12.6.3 Antiretroviral Therapy Introduction
        12.6.4 Mylan Revenue in Antiretroviral Therapy Business (2013-2018)
        12.6.5 Mylan Recent Development
    12.7 Abbvie
        12.7.1 Abbvie Company Details
        12.7.2 Company Description and Business Overview
        12.7.3 Antiretroviral Therapy Introduction
        12.7.4 Abbvie Revenue in Antiretroviral Therapy Business (2013-2018)
        12.7.5 Abbvie Recent Development
    12.8 Bionor Pharma
        12.8.1 Bionor Pharma Company Details
        12.8.2 Company Description and Business Overview
        12.8.3 Antiretroviral Therapy Introduction
        12.8.4 Bionor Pharma Revenue in Antiretroviral Therapy Business (2013-2018)
        12.8.5 Bionor Pharma Recent Development
    12.9 Vertex Pharmaceuticals
        12.9.1 Vertex Pharmaceuticals Company Details
        12.9.2 Company Description and Business Overview
        12.9.3 Antiretroviral Therapy Introduction
        12.9.4 Vertex Pharmaceuticals Revenue in Antiretroviral Therapy Business (2013-2018)
        12.9.5 Vertex Pharmaceuticals Recent Development

13 Market Forecast 2018-2025
    13.1 Market Size Forecast by Regions
    13.2 United States
    13.3 Europe
    13.4 China
    13.5 Japan
    13.6 Southeast Asia
    13.7 India
    13.8 Central & South America
    13.9 Market Size Forecast by Product (2018-2025)
    13.10 Market Size Forecast by Application (2018-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
            15.1.1.1 Research Programs/Design
            15.1.1.2 Market Size Estimation
            12.1.1.3 Market Breakdown and Data Triangulation
        15.1.2 Data Source
            15.1.2.1 Secondary Sources
            15.1.2.2 Primary Sources
    15.2 Disclaimer
    15.3 Author Details

List of Tables and Figures

    Table Antiretroviral Therapy Key Market Segments
    Table Key Players Antiretroviral Therapy Covered
    Table Global Antiretroviral Therapy Market Size Growth Rate by Type 2013-2025 (Million US$)
    Figure Global Antiretroviral Therapy Market Size Market Share by Type 2013-2025
    Figure NNRTIs Figures
    Table Key Players of NNRTIs
    Figure NRTI Figures
    Table Key Players of NRTI
    Figure Multiclass Combination Products Figures
    Table Key Players of Multiclass Combination Products
    Figure Integrase Inhibitors Figures
    Table Key Players of Integrase Inhibitors
    Table Global Antiretroviral Therapy Market Size Growth by Application 2013-2025 (Million US$)
    Figure Hospital Case Studies
    Figure Clinic Case Studies
    Figure Other Case Studies
    Figure Antiretroviral Therapy Report Years Considered
    Table Global Antiretroviral Therapy Market Size 2013-2025 (Million US$)
    Figure Global Antiretroviral Therapy Market Size and Growth Rate 2013-2025 (Million US$)
    Table Global Antiretroviral Therapy Market Size by Regions 2013-2025 (Million US$)
    Table Global Antiretroviral Therapy Market Size by Regions 2013-2018 (Million US$)
    Table Global Antiretroviral Therapy Market Share by Regions 2013-2018
    Figure Global Antiretroviral Therapy Market Share by Regions 2013-2018
    Figure Global Antiretroviral Therapy Market Share by Regions 2018
    Table Market Top Trends
    Table Global Antiretroviral Therapy Revenue by Manufacturers (2013-2018) (Million US$)
    Table Global Antiretroviral Therapy Market Share by Manufacturers (2013-2018)
    Figure Global Antiretroviral Therapy Market Share by Manufacturers in 2018
    Table Global Antiretroviral Therapy Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table Key Players Head office and Area Served
    Table Key Players Antiretroviral Therapy Product/Solution/Service
    Table Date of Enter into Antiretroviral Therapy Market
    Table Mergers & Acquisitions, Expansion Plans
    Table Global Antiretroviral Therapy Market Size by Type (2013-2018) (Million US$)
    Table Global Antiretroviral Therapy Market Size Share by Type (2013-2018)
    Figure Global Antiretroviral Therapy Market Size Market Share by Type (2013-2018)
    Table Global Antiretroviral Therapy Market Size by Application (2013-2018) (Million US$)
    Table Global Antiretroviral Therapy Market Size Share by Application (2013-2018)
    Figure Global Antiretroviral Therapy Market Size Market Share by Application (2013-2018)
    Figure Global Antiretroviral Therapy Revenue Market Share by Application in 2017
    Figure United States Antiretroviral Therapy Market Size 2013-2018 (Million US$)
    Table United States Key Players Antiretroviral Therapy Revenue (2017-2018) (Million US$)
    Table United States Key Players Antiretroviral Therapy Market Share (2017-2018)
    Table United States Antiretroviral Therapy Market Size by Type (2013-2018) (Million US$)
    Table United States Antiretroviral Therapy Market Share by Type (2013-2018)
    Table United States Antiretroviral Therapy Market Size by Application (2013-2018) (Million US$)
    Table United States Antiretroviral Therapy Market Share by Application (2013-2018)
    Figure Europe Antiretroviral Therapy Market Size 2013-2018 (Million US$)
    Table Europe Key Players Antiretroviral Therapy Revenue (2017-2018) (Million US$)
    Table Europe Key Players Antiretroviral Therapy Market Share (2017-2018)
    Table Europe Antiretroviral Therapy Market Size by Type (2013-2018) (Million US$)
    Table Europe Antiretroviral Therapy Market Share by Type (2013-2018)
    Table Europe Antiretroviral Therapy Market Size by Application (2013-2018) (Million US$)
    Table Europe Antiretroviral Therapy Market Share by Application (2013-2018)
    Figure China Antiretroviral Therapy Market Size 2013-2018 (Million US$)
    Table China Key Players Antiretroviral Therapy Revenue (2017-2018) (Million US$)
    Table China Key Players Antiretroviral Therapy Market Share (2017-2018)
    Table China Antiretroviral Therapy Market Size by Type (2013-2018) (Million US$)
    Table China Antiretroviral Therapy Market Share by Type (2013-2018)
    Table China Antiretroviral Therapy Market Size by Application (2013-2018) (Million US$)
    Table China Antiretroviral Therapy Market Share by Application (2013-2018)
    Figure Japan Antiretroviral Therapy Market Size 2013-2018 (Million US$)
    Table Japan Key Players Antiretroviral Therapy Revenue (2017-2018) (Million US$)
    Table Japan Key Players Antiretroviral Therapy Market Share (2017-2018)
    Table Japan Antiretroviral Therapy Market Size by Type (2013-2018) (Million US$)
    Table Japan Antiretroviral Therapy Market Share by Type (2013-2018)
    Table Japan Antiretroviral Therapy Market Size by Application (2013-2018) (Million US$)
    Table Japan Antiretroviral Therapy Market Share by Application (2013-2018)
    Figure Southeast Asia Antiretroviral Therapy Market Size 2013-2018 (Million US$)
    Table Southeast Asia Key Players Antiretroviral Therapy Revenue (2017-2018) (Million US$)
    Table Southeast Asia Key Players Antiretroviral Therapy Market Share (2017-2018)
    Table Southeast Asia Antiretroviral Therapy Market Size by Type (2013-2018) (Million US$)
    Table Southeast Asia Antiretroviral Therapy Market Share by Type (2013-2018)
    Table Southeast Asia Antiretroviral Therapy Market Size by Application (2013-2018) (Million US$)
    Table Southeast Asia Antiretroviral Therapy Market Share by Application (2013-2018)
    Figure India Antiretroviral Therapy Market Size 2013-2018 (Million US$)
    Table India Key Players Antiretroviral Therapy Revenue (2017-2018) (Million US$)
    Table India Key Players Antiretroviral Therapy Market Share (2017-2018)
    Table India Antiretroviral Therapy Market Size by Type (2013-2018) (Million US$)
    Table India Antiretroviral Therapy Market Share by Type (2013-2018)
    Table India Antiretroviral Therapy Market Size by Application (2013-2018) (Million US$)
    Table India Antiretroviral Therapy Market Share by Application (2013-2018)
    Figure Central & South America Antiretroviral Therapy Market Size 2013-2018 (Million US$)
    Table Central & South America Key Players Antiretroviral Therapy Revenue (2017-2018) (Million US$)
    Table Central & South America Key Players Antiretroviral Therapy Market Share (2017-2018)
    Table Central & South America Antiretroviral Therapy Market Size by Type (2013-2018) (Million US$)
    Table Central & South America Antiretroviral Therapy Market Share by Type (2013-2018)
    Table Central & South America Antiretroviral Therapy Market Size by Application (2013-2018) (Million US$)
    Table Central & South America Antiretroviral Therapy Market Share by Application (2013-2018)
    Table Gilead Company Details
    Table Gilead Revenue in Antiretroviral Therapy Business (2013-2018) (Million US$)
    Figure Gilead Revenue Growth Rate in Antiretroviral Therapy Business (2013-2018)
    Table Gilead Recent Development
    Table F. Hoffmann-La Roche Company Details
    Table F. Hoffmann-La Roche Revenue in Antiretroviral Therapy Business (2013-2018)(Million US$)
    Figure F. Hoffmann-La Roche Revenue Growth Rate in Antiretroviral Therapy Business (2013-2018)
    Table F. Hoffmann-La Roche Recent Development
    Table ViiV Healthcare Company Details
    Table ViiV Healthcare Revenue in Antiretroviral Therapy Business (2013-2018)(Million US$)
    Figure ViiV Healthcare Revenue Growth Rate in Antiretroviral Therapy Business (2013-2018)
    Table ViiV Healthcare Recent Development
    Table Boehringer Ingelheim Company Details
    Table Boehringer Ingelheim Revenue in Antiretroviral Therapy Business (2013-2018)(Million US$)
    Figure Boehringer Ingelheim Revenue Growth Rate in Antiretroviral Therapy Business (2013-2018)
    Table Boehringer Ingelheim Recent Development
    Table Janssen Pharmaceuticals Company Details
    Table Janssen Pharmaceuticals Revenue in Antiretroviral Therapy Business (2013-2018)(Million US$)
    Figure Janssen Pharmaceuticals Revenue Growth Rate in Antiretroviral Therapy Business (2013-2018)
    Table Janssen Pharmaceuticals Recent Development
    Table Mylan Company Details
    Table Mylan Revenue in Antiretroviral Therapy Business (2013-2018)(Million US$)
    Figure Mylan Revenue Growth Rate in Antiretroviral Therapy Business (2013-2018)
    Table Mylan Recent Development
    Table Abbvie Company Details
    Table Abbvie Revenue in Antiretroviral Therapy Business (2013-2018)(Million US$)
    Figure Abbvie Revenue Growth Rate in Antiretroviral Therapy Business (2013-2018)
    Table Abbvie Recent Development
    Table Bionor Pharma Company Details
    Table Bionor Pharma Revenue in Antiretroviral Therapy Business (2013-2018)(Million US$)
    Figure Bionor Pharma Revenue Growth Rate in Antiretroviral Therapy Business (2013-2018)
    Table Bionor Pharma Recent Development
    Table Vertex Pharmaceuticals Company Details
    Table Vertex Pharmaceuticals Revenue in Antiretroviral Therapy Business (2013-2018)(Million US$)
    Figure Vertex Pharmaceuticals Revenue Growth Rate in Antiretroviral Therapy Business (2013-2018)
    Table Vertex Pharmaceuticals Recent Development
    Table Global Antiretroviral Therapy Market Size by Regions (Million US$) 2018-2025
    Figure Global Antiretroviral Therapy Market Size Share by Regions (2018-2025)
    Figure Global Antiretroviral Therapy Market Size Share by Regions in 2025
    Figure United States Antiretroviral Therapy Market Size Forecast (2018-2025)(Million USD)
    Figure Europe Antiretroviral Therapy Market Size Forecast (2018-2025)(Million USD)
    Figure China Antiretroviral Therapy Market Size Forecast (2018-2025)(Million USD)
    Figure Japan Antiretroviral Therapy Market Size Forecast (2018-2025)(Million USD)
    Figure Southeast Asia Antiretroviral Therapy Market Size Forecast (2018-2025)(Million USD)
    Figure India Antiretroviral Therapy Market Size Forecast (2018-2025)(Million USD)
    Figure Central & South America Antiretroviral Therapy Market Size Forecast (2018-2025)(Million USD)
    Table Global Antiretroviral Therapy Market Size by Product (2018-2025) (Million US$)
    Figure Global Antiretroviral Therapy Market Size by Product (2018-2025)
    Figure Global Antiretroviral Therapy Market Size by Product in 2025
    Table Global Antiretroviral Therapy Market Size by Application (2018-2025) (Million US$)
    Figure Global Antiretroviral Therapy Market Size by Application (2018-2025)
    Figure Global Antiretroviral Therapy Market Size by Application in 2025
    Table Research Programs/Design for This Report
    Figure Bottom-up and Top-down Approaches for This Report
    Figure Data Triangulation
    Table Key Data Information from Secondary Sources
    Table Key Data Information from Primary Sources